Full-thickness burn injury results in a continuous deterioration of bl
ood flow due to vascular sludging, thrombosis formation and oedema lea
ding to irreversible ischaemia and tissue necrosis. D-myo-inositol-1,2
,6-trisphosphate (IP3) has previously been shown to reduce burn-induce
d oedema formation and inflammation involved in the pathophysiology of
progressive ischaemia. A full-thickness burn injury (1 cm(2)) was ind
uced in the abdominal skin of anaesthetized rats using an electrically
heated thermoprobe. Blood flow in the experimental area was measured
by laser Doppler flowmetry during 6. 5 h postburn. The experiments inc
luded five groups. Three burned groups were treated intravenously with
IP3 and received respectively: a bolus dose of 4 mg/kg followed by a
continuous intravenous infusion of 20 mg/kg/h, 8 mg/kg + 40 mg/kg/h or
16 mg/kg + 60 mg/kg/h. One burned and one unburned control group rece
ived a corresponding bolus dose and infusion of saline. Results showed
a significant inhibition of dermal ischaemia in the burned groups rec
eiving IP3 at all dose intervals as compared to saline-treated burned
rats (all P < 0.001). We conclude that IP3 improved local dermal perfu
sion in burned skin. Probable mechanisms of action could be the vasodi
latory and anti-inflammatory properties of the agent. Copyright (C) 19
96 Elsevier Science Ltd for ISBI.